Company Overview
Snapshot
Founded in August 2018 by Claudia M Barzilay, Nanomedic Technologies operates with 11–50 employees. The company has raised $13.01 million across 8 funding rounds from 3 investors. In March 2021, Nanomedic Technologies appointed Mark Darty as CEO and opened its U.S. headquarters, signaling an acceleration of its global expansion strategy.
Business overview
Nanomedic Technologies is a biomedical therapeutics technology company focused on advanced wound treatment. The company specializes in the research, development, and distribution of its innovative EHF technology and SpinCare System platform. Its electrospinning EHF technology biomimics the natural structure of human tissue, providing a temporary skin substitute that promotes tissue integration and regeneration to expedite recovery. The portable SpinCare System also allows for the slow release of therapeutic additives into wounds. Nanomedic operates in the Health Tech & Life Sciences sector, specifically within Medical Devices and Medical Treatment & Therapeutics, serving healthcare providers in markets such as North America.
Strategic signal
In September 2021, Nanomedic Technologies established its U.S. headquarters in Memphis, indicating a strategic move to expand its presence and market penetration in North America. This development signals the company's commitment to global growth and its readiness to scale operations in a key market for medical devices and wound care solutions, positioning it for increased commercial opportunities and partnerships.
Log in to access full profile ›Company Intelligence Q&A
- What is Nanomedic Technologies' core product?
- Nanomedic Technologies' core product is the SpinCare System, which utilizes EHF electrospinning technology to create a temporary skin substitute for advanced wound treatment. This system is designed to biomimic natural tissue structure and facilitate tissue regeneration.
- When did Nanomedic Technologies appoint its current CEO and establish its U.S. headquarters?
- In March 2021, Nanomedic Technologies appointed Mark Darty as CEO and opened its U.S. headquarters, indicating a strategic move towards accelerating global expansion.
- What was a significant strategic development for Nanomedic Technologies in the U.S. market?
- In September 2021, Nanomedic Technologies based its U.S. headquarters in Memphis, Tennessee, as part of its plans for expansion in the American market.
- Which investors participated in Nanomedic Technologies' funding rounds?
- Investors such as OurCrowd and Citrine Global have participated in funding rounds for Nanomedic Technologies.
- What is the primary application of Nanomedic Technologies' electrospinning technology?
- Nanomedic Technologies' electrospinning EHF technology is primarily used to create a temporary skin substitute that encourages quick and efficient tissue integration and regeneration to expedite recovery from wounds.